Lankenau Hospital — Wynnewood, Pennsylvania

Lankenau Hospital is a clinical research site located in Wynnewood, Pennsylvania, United States 19096.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Lankenau Hospital has participated in 31 clinical trials with 2 currently active.

Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Sponsors: National Cancer Institute (NCI), Novartis, Boston Scientific Corporation.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lankenau Hospital?

Lankenau Hospital has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lankenau Hospital conducted?

Lankenau Hospital has 31 clinical trials on record, with 2 currently active. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.

Is Lankenau Hospital accredited by Crixeo Health?

Yes — Lankenau Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lankenau Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.